The High Tech CEO
News and Events
- 2024
- 2023
- 2022
- Shane Kenny Memorial Biotechnology Lecture Tuesday 22nd February 2022
- The High Tech CEO
- (opens in a new window)ENGAGE 2022 Grand Final
- Acclimatize Summer Studentships
- ENGAGE 2022 Accessible Science
- (opens in a new window)Acclimatize - Leave Only Paw Prints
- Class of 2022 MSc Graduation & Medal Awards
- Class of 2022 Graduation
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- Vacancies
The High Tech CEO
Professor Jan Rosier's new book (opens in a new window)'The High Tech CEO - How to Lead R&D When You're Not the Expert' has been published by the Routledge, Taylor & Francis Group.
From the publisher:
This book examines the impact of CEOs on firm performance and focuses on their role in science-based innovation to answer the question, is it possible to lead highly complex R&D projects and innovation that you do not understand?
Today, science and technology move so fast that even managers of R&D teams can become quickly disconnected from new developments. Similarly, business leaders may be required to lead organisations with technical knowledge beyond their own expertise. How to manage teams and retain respect and influence is a recognised challenge. Filled with insight from managers and CEOs in science and technology organisations, the book unlocks the skills required to balance the leadership and managerial needs of the organisation, motivate the technical teams and drive successful innovation in new product development environments. Due to the vital role played by experts in a chosen field of technical and scientific expertise, the book also describes what these specialists need and expect from their leaders.
The book is required reading for managers in high tech and scientific environments – the CEO, CSO and the R&D manager. It can also be used as a classroom reference book on the management skills required for leading high-tech projects.
Professor Rosier is the ELAN Professor of The Business of Biotechnology at UCD, a joint chair shared between the School of Biomolecular and Biomedical Science and the Michael Smurfit Graduate Business School.